Table 1.
Demographic and clinical characteristics of the three groups
| Control n = 42 |
AD-MCI n = 42 |
ADD n = 41 |
Statistical results | |
|---|---|---|---|---|
| Agea | 73.7 ± 7.4 | 74.8 ± 7.8 | 77.3 ± 6.1 | F(2,122) = 2.6, p = 0.08 |
| Gender (% male)b | 50 | 38 | 39 | χ2 = 1.5, p = 0.47 |
| Educational levela | 9.9 ± 3.3 | 9.2 ± 4.5 | 8.2 ± 4.4 | F(2,122) = 2.5, p = 0.08 |
| MMSEa | 28.9 ± 0.9 | 25.0 ± 1.0 | 21.5 ± 1.1 | F(2,122) = 631.6, p < 10− 4 |
Data are presented as mean ± standard deviation
ADD Alzheimer’s disease with dementia, AD-MCI mild cognitive impairment due to Alzheimer’s disease, MMSE mini-mental state examination
aANOVA analysis. Duncan post-hoc comparisons for MMSE. MMSE higher in control than in AD-MCI (p = 10− 4) and ADD (p = 10− 4). MMSE was higher in AD-MCI than ADD (p = 10− 4)
bKruskal–Wallis test